Noctyl Valerian Root Extract Capsules 170 mg Capsule is a Health Canada–registered human drug (DIN 02239996) held by Ashbury Research Corporation, containing Valerian. Health Canada lists its status as Cancelled Pre Market (status date 05 Jul 2022). Nexara Health has matched 10 registrations of Valerian across 2 other regulated markets.
Health Canada registration
| DIN | 02239996 |
|---|---|
| Brand name | Noctyl Valerian Root Extract Capsules |
| Active ingredient | Valerian |
| Strength | 170 mg |
| Dosage form | Capsule |
| Route | Oral |
| Company | Ashbury Research Corporation |
| Status | Cancelled Pre Market — 05 Jul 2022 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Valerian registered in other markets
10 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Bulgaria | Tinctura Valerianae Chemax Pharma | Химакс Фарма ЕООД | 200mg/ml oral drops, solution | капки перорални, разтвор | Без лекарско предписание | BDA |
| Bulgaria | Tinctura Valerianae Kupro | "Купро 94" ООД | 200 mg/ml oral drops, solution | капки перорални, разтвор | Без лекарско предписание | BDA |
| Bulgaria | Valeriana | Софарма Ад | 30 mg film - coated tablets | таблетка филмирана | Без лекарско предписание | BDA |
| United States | Valeriana officinalis | Boiron | Pellet | listed | FDA NDC | |
| United States | Valeriana Officinalis | Boiron | Pellet | listed | FDA NDC | |
| United States | Valeriana Officinalis | Boiron | Pellet | listed | FDA NDC | |
| United States | Valeriana Officinalis | Boiron | Pellet | listed | FDA NDC | |
| United States | Valeriana Officinalis | Boiron | Pellet | listed | FDA NDC | |
| United States | Valeriana Officinalis | Boiron | Pellet | listed | FDA NDC | |
| United States | Valeriana Officinalis Kit Refill | Washington Homeopathic Products | Pellet | listed | FDA NDC |
See every manufacturer of Valerian worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Noctyl Valerian Root Extract Capsules (DIN 02239996) marketed in Canada?
No. Health Canada lists DIN 02239996 as Cancelled Pre Market as of 05 Jul 2022.
Who holds the Canadian licence for this product?
Ashbury Research Corporation is the company of record in the Health Canada Drug Product Database.
Is Valerian registered outside Canada?
Yes — Nexara Health has matched 10 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02239996, status date 2022-07-05; national medicine registries: BDA, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02239996, status date 2022-07-05; national medicine registries: BDA, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02239996, status date 2022-07-05; national medicine registries: BDA, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.